Chinhoyi University of Technology researchers have made promising steps toward creating a herbal-based antivenom. Their new formula works against many snake toxins, unlike current treatments that target only specific snake types. The research draws from traditional knowledge used throughout history for snakebite treatment.
The new antivenom fights various venom effects—those attacking nerves, blood, cells at the bite site, and muscle tissue. Early tests show some herbs build resistance before exposure to venom, with others offering treatment after bites. The university is working on this innovation as Zimbabwe faces shortages of Indian-imported antivenom, with nine deaths reported from over 2,300 snakebites since January.
Researcher Takura Gozho reports positive early results for the multi-purpose herbal formula. Current treatments require healthcare workers to identify the exact snake species, often difficult, before giving the correct antivenom. The new formula would help people in high-risk areas such as farms and rural communities.
CUT has started talks with the Medicines Control Authority of Zimbabwe about clinical trials. Tests both outside living organisms and within animal models show the treatment works well. A successful local antivenom would solve problems with imported medicine effectiveness and high costs, as a single dose currently costs around $700.
The new antivenom fights various venom effects—those attacking nerves, blood, cells at the bite site, and muscle tissue. Early tests show some herbs build resistance before exposure to venom, with others offering treatment after bites. The university is working on this innovation as Zimbabwe faces shortages of Indian-imported antivenom, with nine deaths reported from over 2,300 snakebites since January.
Researcher Takura Gozho reports positive early results for the multi-purpose herbal formula. Current treatments require healthcare workers to identify the exact snake species, often difficult, before giving the correct antivenom. The new formula would help people in high-risk areas such as farms and rural communities.
CUT has started talks with the Medicines Control Authority of Zimbabwe about clinical trials. Tests both outside living organisms and within animal models show the treatment works well. A successful local antivenom would solve problems with imported medicine effectiveness and high costs, as a single dose currently costs around $700.
